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Asthma Management Programs in 
Managed Care Organizations
CHRISTINE W. HARTMANN, M.S.S., Ph.D., VITTORIO MAIO, Pharm.D., M.S., 
NEIL I. GOLDFARB, NICOLE COBB, M.A.O.M., and DAVID B. NASH, M.D., M.B.A.
ABSTRACT
The aim of this work was to investigate how managed care organizations (MCOs) currently
approach asthma treatment and management and to determine factors affecting asthma out-
comes. A Web-based survey was administered to a national sample of 351 medical directors
of MCOs to investigate the asthma management program components in their organizations
as well as gaps and barriers in the management of patients with asthma. All 134 (38.2%) re-
sponding medical directors reported that their organizations monitor asthma patients. Plans
use a variety of asthma management activities, including general member education (90%),
member education by mail (87%), self-management education (85%), and provider education
(82%). Educational resources (89%) and telephone advice nurse (77%) were the most common
self-management strategies offered. Among factors impeding the provision of effective
asthma care, noncompliance with asthma treatment, the inappropriate use of medications, and
the need for multiple medications were cited by virtually all respondents. Health plans rely
on an array of strategies to manage asthma patients. Education encouraging patient self-man-
agement is a key component of asthma management programs. However, a considerable num-
ber of treatment approach barriers are impeding the achievement of proper asthma care. With-
out innovative approaches to care, it appears that current MCOs’ asthma management efforts




WITH ITS GENERAL INCREASE in prevalence,morbidity, and mortality over the last
decades, asthma is one of the most prominent
and costly public health challenges in children
and adults.1–3 Currently, asthma affects ap-
proximately 15 million individuals in the
United States. On an annual basis, 5,000 deaths,
500,000 hospitalizations, and 2 million emer-
gency department visits are attributed to
asthma.4–6 In addition, asthma accounts for 14
million school absence days and 14.5 million
work absence days annually.4 Accordingly, the
economic impact for society is astonishing: di-
rect and indirect health care costs for asthma
were estimated to be $12.7 billion in 1998.1,6,7
According to the National Heart, Lung, and
Blood Institute’s (NHLBI) current guidelines,
asthma treatment entails a multilevel interven-
tion including appropriate pharmacological
therapy, patient education, control of asthma
Department of Health Policy, Jefferson Medical College, Philadelphia, Pennsylvania.
triggers, and monitoring of asthma severity with
objective measures of lung function.1 The litera-
ture reports, however, that compliance with
guidelines falls short.8–10 Suboptimal use of ef-
fective medications, gaps in communication be-
tween patients and physicians, and inadequate
patient disease self-management are among the
most important reasons for this failure.11
With the objectives of optimizing the process
of care provided to patients and enhancing
healthcare outcomes, disease management (DM)
programs for asthma have become a priority for
managed care organizations (MCOs). For almost
a decade, encouraged by a number of successful
programs showing improvements in terms of
both clinical and humanistic outcomes,12–17
asthma DM programs have been flourishing
across the country. One survey of members of
America’s Health Insurance Plans (formerly the
American Association of Health Plans) reported
that over three quarters of plans surveyed had
an asthma DM program in place in 2000.18 How-
ever, there is limited information on how such
programs are structured. The purpose of this sur-
vey was to determine how MCOs currently ap-
proach asthma treatment and management, and
to identify their biggest challenges and opportu-
nities in improving asthma outcomes.
METHODS
A Web-based survey was conducted in April
and May of 2004. The target population of the
survey consisted of all medical directors of MCOs
in the United States. The sample list was obtained
from InterStudy Publication’s Competitive Edge
Part I & II (version 13.2), which provided 455
medical directors’ names and addresses, listed as
of January 1, 2003 (the most recent available list-
ing at the time the study was initiated). Duplicate
names were removed. The list was subsequently
cross-tabulated with the Department of Health
Policy’s database of managed care medical di-
rectors to determine email addresses and direct
telephone numbers. Efforts were made to obtain
accurate e-mail addresses and phone numbers of
all medical directors listed.
The final sample consisted of 351 medical di-
rectors. A letter of invitation was e-mailed to
all potential respondents in the cleaned list, ex-
plaining the survey and asking for their par-
ticipation in the survey. A link to the online sur-
vey instrument was provided in the letter. Po-
tential participants were assured of the
confidentiality of the information collected. A
financial incentive of $50 upon completion of
the questionnaire also was offered.
Data collection
A survey questionnaire was developed by the
project team and mounted on the online survey
portal www.SurveyMonkey.com. The instru-
ment contained questions regarding descriptive
plan information, asthma management pro-
gram components, and gaps and barriers in the
management of patients with asthma. All sur-
vey instruments and procedures were reviewed
and approved by the Thomas Jefferson Univer-
sity Institutional Review Board.
Responses were tracked through the survey
portal. Three follow-up emailings were sent
in 1-week intervals to non-respondents, and
those who requested a printed copy of the
survey were sent one. Two weeks after the 
final follow-up mailing, phone calls were
placed to a random sample of 20 non-re-
spondents to determine whether making di-
rect phone calls would further elevate re-
sponse rates. This attempt was unsuccessful:
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TABLE 1. CHARACTERISTICS OF MANAGED
CARE ORGANIZATIONS (n  134)
Enrollment size
n (%)a,b
by book of businessc Commercial Medicaid Medicare
None 23 (17) 52 (40) 75 (57)
1–50,000 28 (21) 41 (31) 39 (30)
50,001–100,000 21 (16) 19 (14) 8 (6)
100,001–500,000 35 (27) 16 (12) 6 (5)







aTotals may not sum 100% due to rounding.
bNot available for all respondents.
cMultiple-response question.
dCharacterized as those MCOs reporting member-
ship in at least two regions.
only one director out of the 20 completed the
survey online. The survey was officially closed
2 weeks after the final follow-up mailing.
All responses were entered into the form on
the survey Web site, either by the respondents
themselves or, for respondents who completed
the printed instrument, by a survey staff mem-
ber. The complete data file was subsequently
downloaded in the form of an Excel spread-
sheet (Microsoft Corp, Redmond, WA).
Statistical analysis
Data were analyzed using SAS (SAS Insti-
tute, version 8.2, Cary, NC). Descriptive statis-
tics were calculated for all variables.
RESULTS
In all, 134 medical directors completed the
online survey, either online (n  132) or in writ-
ing (n  2), and 34 declined to participate. The
final response rate was 38.2%, based on 134 re-
sponses out of a sample of 351. The completion
rate was 42.3%, based on 134 responses out of
the sample of 317 directors who did not decline.
Respondents were asked to identify basic de-
mographic characteristics of their organiza-
tions (Table 1). Most of the plans (83%) had
some commercial members, 60% had some
Medicaid members, and 43% had some
Medicare members. Responses were well-dis-
tributed around the country, with a slight ma-
jority coming from either the Midwest (29%) or
the South (23%).
Methods used by the responding MCOs to
identify patients with asthma are described in
Table 2. Information collected through this
multiple-response question indicates that al-
most all responding organizations used claims
or encounter data such as CPT-4 or ICD-9 codes
(97%) and pharmacy utilization data such as
NDC codes (97%) to identify patients. More
than half of these organizations also used care
manager referrals (75%), physician referrals
(68%), self-referral (58%), or the Health Plan
Employer Data and Information Set (HEDIS)
measures (55%). Only two organizations did
not identify asthma patients at all.
With regard to asthma management activi-
ties conducted by responding organizations,
there was a large gap between activities pur-
sued by most organizations and those pursued
only by some (Table 3). The most popular ac-
tivities were general member education (90%),
member education by mail (87%), self-man-
agement education (85%), and provider educa-
tion (82%). Internet member education was
pursued by roughly half of the organizations,
while member incentives to encourage compli-
ance and pharmacy benefit were pursued by
only 11% and 10%, respectively.
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TABLE 2. METHODS OF IDENTIFYING PATIENTS
WITH ASTHMA (n  134)
Measurement n (%)a,b
Claims or encounter date (e.g., CPT-4, 129 (97)
ICD-9 codes)
Pharmacy utilization data (e.g., NDC 129 (97)
codes)
Care manager referral 100 (75)
Physician referral 91 (68)
Self-referral 77 (58)
HEDIS 73 (55)
Predictive modeling software 41 (31)
Member interview or self-assessment 41 (31)
Other 5 (4)
We do not identify patients with asthma 2 (2)
aMultiple-response question.
bAvailable for 133 respondents.
TABLE 3. ASTHMA MANAGEMENT ACTIVITIES (n  134)
Component n (%)a,b
General member education 118 (90)
Member education by mail 114 (87)
Self-management education 111 (85)
Provider education 108 (82)
Internet member education 64 (49)
Information Technology member support 31 (24)
Member incentives to encourage compliance 15 (11)
Pharmacy benefit, e.g., waiver of copays 13 (10)
Other management strategy 19 (15)
aMultiple-response question.
bAvailable for 131 respondents.
As evidenced by the data in Table 3, asthma
self-management strategies comprised part of
most organizations’ asthma management ac-
tivities. The specific types of self-management
strategies offered are detailed in Table 4. Only
5% of the organizations reported using no self-
management strategies. Educational resources
were most frequently employed (89%), with
telephone advice nurse services also being used
by over three quarters of responding organiza-
tions. Almost 60% of the organizations also
made use of self-assessment of peak flow and
behavior modification programs.
Organizations also were asked about the
ways in which they assessed the effectiveness
of the management of members with asthma
(Table 5). There was a large variation in the
types of measures used. Most plans were ex-
amining emergency room (95%) and inpatient
hospital (91%) service utilization. Other fre-
quently used measures included pharmacy
cost utilization (80%) and quality measures
such as HEDIS and Foundation for Account-
ability (FACCT; 78%). Organizations also
were interested in oral steroid use (60%). All
other methods, including member satisfac-
tion, return on investment, clinical outcome
measures, and days missed from work or
school were used by fewer than half the or-
ganizations.
Respondents were asked to rate on a three-
item scale (not at all, somewhat, and exten-
sively) the extent to which certain factors im-
peded the provision of effective asthma care
from the perspective of the MCO (Table 6).
Based on a total percentage combination of the
somewhat and extensively categories, non-
compliance with asthma treatment and inap-
propriate use of medications were cited as im-
peding factors by 99% (all but one respondent)
and 97% (all but four respondents), respec-
tively. Other frequently cited impeding factors
include the need for taking multiple medica-
tions (96%), the variability of the disease within
an individual (95%), patient psychosocial is-
sues (94%), and lack of provider awareness of
the NHLBI guidelines for asthma (83%).
In a related question, respondents were asked
to rate, using a three-item scale (does not, some-
what, and significantly), the factors that affect
member compliance with the prescribed treat-
ment regimen (Table 7). Patient misunderstand-
ing of the role of prescribed medications in man-
aging asthma was rated as significantly affecting
compliance by 79% of the respondents, while
lack of basic knowledge about asthma as a dis-
ease and lack of understanding of specific per-
sonal asthma triggers were cited as significant
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TABLE 4. MEMBER SELF-MANAGEMENT STRATEGIES
OFFERED (n  134)
Component n (%)a,b
Educational resources 119 (89)
Telephone advice nurse 102 (77)
Self-assessment of peak flow 79 (59)
Behavior modification programs 77 (58)
Home visits (assessment of environmental 46 (35)
triggers)
Member/dependent skills training 46 (35)
Other self-management strategies 6 (5)
No self-management strategies 6 (5)
aMultiple-response question.
bAvailable for 133 respondents.
TABLE 5. METHODS OF ASSESSING THE EFFECTIVENESS
OF MANAGING MEMBERS WITH ASTHMA (n  134)
Measurement n (%)a,b
Emergency room utilization 124 (95)
Inpatient utilization 118 (91)
Pharmacy costs/utilization 104 (80)
Quality measures (eg, HEDIS, FACCT) 101 (78)
Oral steroid use 78 (60)
Member satisfaction 55 (42)
Specialist utilization 41 (32)
Return on investment 38 (29)
Clinical outcome measures (eg, peak flow) 34 (26)
Functional status assessment 33 (25)
Lost work days 22 (17)
Lost school days 21 (16)
Provider satisfaction 19 (15)
Employer satisfaction 8 (6)
Member longevity program 8 (6)
Other 3 (2)
aMultiple-response question.
bAvailable for 130 respondents.
factors by 73% and 68%, respectively. Overall,
medication safety or concerns about side effects
ranked lowest, with 19% of respondents indicat-
ing that it was not an issue, and 71% indicating
it was somewhat an issue.
Respondents were asked to outline their be-
liefs regarding members’ use of asthma med-
ications (Table 8). To this single-response ques-
tion, only 5% of respondents indicated that
they believed members used medications as
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TABLE 6. FACTORS IMPEDING ACHIEVEMENT OF EFFECTIVE ASTHMA CARE (n  134)
n (%)a,b
Factor Not at all Somewhat Extensively
Member noncompliance with asthma treatmentc 1 (1) 63 (48) 68 (52)
Member inappropriate use of medicationsd 4 (3) 80 (60) 49 (37)
Variability of the disease within an individuald 7 (5) 86 (65) 40 (30)
Member need to take multiple medicationsc 5 (4) 88 (67) 39 (30)
Member psychosocial issuese 8 (6) 86 (67) 35 (27)
Lack of provider awareness of the NHLBI Guidelines for 22 (17) 86 (65) 25 (19)
Asthmad
Resource limitations (financial and non-financial)d 24 (18) 85 (64) 24 (18)
Member literacy leveld 18 (14) 96 (72) 19 (14)
Inability of providers to follow up with patientsc 32 (24) 81 (61) 19 (14)
Cost of the program for member, for asthma-related servicesd 60 (45) 56 (42) 17 (13)
Individual member response to asthma medicationsd 14 (11) 103 (77) 16 (12)
Multicultural issuesc 19 (14) 103 (78) 10 (8)
Information technology limitationsd 54 (41) 72 (54) 7 (5)
Plan inability to identify members with asthmac 87 (66) 40 (30) 5 (4)
aMultiple-response question.
bTotals may not sum 100% due to rounding.
cAvailable for 132 respondents.
dAvailable for 133 respondents.
eAvailable for 129 respondents.
TABLE 7. FACTORS AFFECTING COMPLIANCE WITH PRESCRIBED TREATMENT REGIMEN (N  134)
n (%)a
Factor Does not Somewhat Significantly
Misunderstanding the role of prescribed medications in 0 28 (21) 103 (79)
managing his/her asthmab,d
Lack of basic knowledge of asthma as a diseasec,d 2 (2) 34 (26) 96 (73)
Lack of understanding of his/her specific asthma triggersb,d 1 (1) 41 (31) 89 (68)
Need to use multiple medicationsb,d 0 69 (53) 62 (47)
Cost/financial concernsc 8 (6) 68 (51) 57 (43)
Medication safety/side effect concernsc,e 24 (19) 91 (71) 14 (11)
aTotals may not sum 100% due to rounding.
bAvailable for 132 respondents.
cAvailable for 133 respondents.
dOne respondent marked “not sure” category (not included in table analyses).
eFour respondents marked “not sure” category (not included in table analyses).
prescribed. The majority of respondents (65%)
believed that members overutilized “rescue”
medications and underutilized “control” med-
ications. Regarding underutilization alone,
20% believed this to be the case, and 5% be-
lieved that members overutilized “rescue”
medications.
DISCUSSION
This national survey of managed care med-
ical directors provides evidence that asthma is
widely recognized as an important target for
disease (and cost) management efforts. Re-
sponding managed care medical directors rec-
ognized that education encouraging patient
self-management is needed in order to over-
come barriers to achieving asthma care goals
due to member noncompliance and inappro-
priate use of medications. They indicated that
these barriers are compounded by the com-
plexity of pharmacotherapy, reliance on multi-
ple medications, and attempts to address vari-
ability of disease across individual patients.
The majority of respondents believed that pa-
tients are not receiving medication therapy
consistent with NHLBI guidelines but instead
are over-reliant on rescue therapies and under-
adherent to control medication. Paradoxically,
despite these recognized challenges, most re-
sponding plans had traditional patient and
provider education programs in place, and
fewer plans were engaged in more innovative
strategies, such as those employing technology
or financial incentives, to influence behavior.
Based on the data collected, the evaluation of
the effectiveness of asthma management strate-
gies also relied more heavily on traditional mea-
sures of service utilization and cost, rather than
on clinical and humanistic outcomes. Only 26%
of respondents were measuring clinical out-
comes such as peak flows, and 17% of plans re-
ported measuring lost productivity. The survey
results provide some confirmation that, while
plans are concerned with providing high qual-
ity, the metrics used to evaluate programs still
are largely focused on costs.
Subgroup analyses did not reveal any major
differences in barriers to management or 
management approaches across regions, or by
panel size or type (commercial, Medicaid, or
Medicare), demonstrating that the managed
care community faces common challenges 
to management of asthma. Therefore, plans
which are experimenting with new and inno-
vative approaches to management are encour-
aged to evaluate their efforts using a variety of
relevant metrics and to share these findings
with the broader managed care community.
The largest limitation to interpreting results
from a survey research project often is the po-
tential for response bias (ie, respondents dif-
fered systematically from nonrespondents). In
this survey of the most senior medical directors
in a 100% sample of health plans, a 38% re-
sponse rate was achieved. It is possible that
nonresponders were more likely to be those
plans which are not actively involved in
asthma management, and although the de-
scriptive statistics in Table 1 suggest that the
sample was representative with regard to dem-
ographic characteristics, results should be gen-
eralized with caution. An additional potential
for bias arises from the survey being targeted
to medical directors, who may tend to explain
gaps in care in a similar fashion across many
disease states. Furthermore, the survey con-
sisted of close-ended items and may not have
adequately captured the depth or variation in
participants’ experiences.
CONCLUSION
This national survey of managed care med-
ical directors supports the position that asthma
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TABLE 8. ASTHMA MEDICATIONS USED BY
MEMBERS (n  134)a
n (%)
Overutilization of “rescue” medications 86 (65)
and underutilization of “control”
medications 
Underutilization of “control” medications 26 (20)
Overutilization of “rescue” medications 7 (5)
Use of medications as prescribed 7 (5)
Do not know 4 (3)
Other 3 (2)
aAvailable for 133 respondents.
management is receiving attention from nearly
all managed care plans. Education, particularly
regarding self-management, appears to be an
essential part of most plans’ approaches to dis-
ease and cost management. However, given the
inherent complexity in administering current
pharmacotherapies, these existing educational
efforts alone may not be enough to improve
outcomes significantly. In the future, the avail-
ability of simplified therapeutic options may
help, and overall, more innovative, multidi-
mensional approaches should be developed
and evaluated using a variety of metrics.
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